期刊文献+

不同途径的供者淋巴细胞输注对移植物抗宿主病的影响 被引量:3

Influence of intra-bone marrow injection of donor lymphocytes upon the development of graft-versus-host disease
下载PDF
导出
摘要 目的:观察髓腔内供者淋巴细胞输注(IBM-DLI)对异基因小鼠外周造血干细胞移植(allo-PBSCT)后移植物抗宿主病(GVHD)的影响。方法:雌性C57BL/6小鼠为受鼠,接受全身照射(TBI)预处理后,输注雄性BALB/c小鼠来源的经rhG-CSF动员后的外周造血干细胞,分别经尾静脉(IV)和髓腔内进行DLI,建立异基因GVHD模型,观察移植后小鼠的生存状态和GVHD发生情况,应用流式细胞仪检测受鼠体内嵌合体形成和CD4+CD25+调节性T细胞(Tregs)比例,酶联免疫吸附实验(ELISA)检测白细胞介素4(IL-4)、γ干扰素(IFNγ-)水平。结果:IBM-DLI组的受鼠GVHD发生比例和严重程度较IV-DLI组明显降低(P<0.01);移植后第7天各组受鼠骨髓中供鼠来源的细胞比例均在95%以上;与IV-DLI组比较,脾细胞中Tregs比例在IBM-DLI组明显升高(P<0.01),IBM-DLI组IL-4分泌增多,IFNγ-分泌减少(P<0.01)。结论:与IV-DLI相比,IBM-DLI有利于减轻GVHD的发生,其机制可能与受鼠体内Tregs细胞比例增高以及Th细胞向Th2细胞分化有关。目的:观察髓腔内供者淋巴细胞输注(IBM-DLI)对异基因小鼠外周造血干细胞移植(allo-PBSCT)后移植物抗宿主病(GVHD)的影响。方法:雌性C57BL/6小鼠为受鼠,接受全身照射(TBI)预处理后,输注雄性BALB/c小鼠来源的经rhG-CSF动员后的外周造血干细胞,分别经尾静脉(IV)和髓腔内进行DLI,建立异基因GVHD模型,观察移植后小鼠的生存状态和GVHD发生情况,应用流式细胞仪检测受鼠体内嵌合体形成和CD4+CD25+调节性T细胞(Tregs)比例,酶联免疫吸附实验(ELISA)检测白细胞介素4(IL-4)、γ干扰素(IFN-γ)水平。结果:IBM-DLI组的受鼠GVHD发生比例和严重程度较IV-DLI组明显降低(P<0.01);移植后第7天各组受鼠骨髓中供鼠来源的细胞比例均在95%以上;与IV-DLI组比较,脾细胞中Tregs比例在IBM-DLI组明显升高(P<0.01),IBM-DLI组IL-4分泌增多,IFN-γ分泌减少(P<0.01)。结论:与IV-DLI相比,IBM-DLI有利于减轻GVHD的发生,其机制可能与受鼠体内Tregs细胞比例增高以及Th细胞向Th2细胞分化有关。 Objective:To investigate the effect of donor lymphocyte infusion (DLI) by intra-bone marrow (IBM) or intravenous (IV) on the incidence of graft-versus-host disease(GVHD) after allogeneic peripheral hematopoietic stem cell transplantation (allo-PBSCT). Methods:Female C57BL/6 mice as recipients received total body irradiation (TBI) on day 0, followed by injection of peripheral hematopoietic stem cells from mobilized male BALB/c with granulocyte-colony stimulating factor (rhG-CSF) ,and DLI was performed via IV or IBM.The extent of GVHD was compared in recipients received allogeneic IBM-DLI with those received IV-DLI. The percentage of donor-derived cells and CD4+ CD25+ regulatory T cells (Tregs) was detected by flow cytometry. 14 days after DLI,the levels of IL-4 and interferon (IFN)-γ were tested by ELISA.Results:It was found that the frequency and severity of GVHD were reduced in IBM-DLI compared with that of IV-DLI (P 〈 0.01). 7 days after transplantation,the percentage of H-2a-positive cells was over 95% in all surviving transplanted mice;and 14 days after transplantation, the percentage of Tregs detected as CD4+ CD25+ was significantly higher in recipients treated with IBM-DLI than those treated with IV- DLI( P 〈 0.01 ). Compared with that of the recipients in IBM-DLI group, the level of IL-4 was significantly decreased, while the level of IFN-γ were elevated in group IV-DLI ( P 〈 0.01). Conclusion: IBM-DLI could induce the proliferation of Tregs and the Th polarizing to Th2, resulting in decreasing the incidence and alleviating severity of GVHD after allo-PBSCT.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2009年第11期999-1002,共4页 Chinese Journal of Immunology
关键词 供者淋巴细胞输注 移植物抗宿主病 细胞因子 调节性T细胞 Donor lymphocyte infusion Graft-versus-host disease Cytokine Regulatory T cells
  • 相关文献

参考文献13

  • 1Reisner Y, Martelli M F. Transplantation tolerance induced by "megadose" CD34^+ cell transplants[J]. Exp Hematol,2000;28(2) : 119-127.
  • 2陈宝安,毕延智,张琰,丁家华,孙雪梅,董伟民.异基因小鼠髓腔内骨髓移植诱导免疫耐受[J].中华器官移植杂志,2006,27(6):334-336. 被引量:4
  • 3Cooke K R, Kobzik L, Martin T R et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation : The roles of minor H antigens and endotoxin [ J ]. Blood, 1996; 88 (8) : 3230-3239.
  • 4Bryson J S,Jennings C D,Lowery D M et al. Rejection of an MHC class Ⅱ negative tumor following induction of murine syngeneic graft-versus-host disease[J]. Bone Marrow Transplant, 1999 ; 23 (4) : 363-372.
  • 5孙爱红,冯四洲,刘斌,汤锋武,冯义,卢士红,韩忠朝.NOD/SCID小鼠脐血单个核细胞骨髓腔内移植的实验研究[J].中华血液学杂志,2005,26(5):261-264. 被引量:14
  • 6Qing L, Hiroko H, Ryoji Y et al. Analyses of very early hemopoietic regeneration after bone marrow transplantation: comparison of intravenous and intrabone marrow routes [ J ]. Stem Cells, 2007 ; 25 ( 5 ) : 1186-1194.
  • 7毕延智,宋红蕾,曾冬香,凌扬,陈宝安.不同干细胞骨髓腔内输注对移植物抗宿主病和免疫耐受的影响[J].现代免疫学,2007,27(4):341-344. 被引量:3
  • 8Yasushi K, Yasushi A, Yasuhiro Set al. Allogeneic intrabone marrowbone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats[J].Stem Cells,2007;25(2) :385-391.
  • 9Sakaguchi S, Sakaguchi N, Asano Met al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance cause various autoimmune diseases[J]. J Immunol, 1995 ; 155 (3) : 1151-1164.
  • 10Hanash A M, Levy R B. Donor CD4^+CD25^+ T ceils promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation[J]. Blood, 2005 ; 105(4) : 1828-1836.

二级参考文献26

  • 1孙爱红,冯四洲,刘斌,汤锋武,冯义,卢士红,韩忠朝.NOD/SCID小鼠脐血单个核细胞骨髓腔内移植的实验研究[J].中华血液学杂志,2005,26(5):261-264. 被引量:14
  • 2毕延智,曾冬香,陈宝安.髓腔内骨髓移植诱导异基因小鼠皮肤移植耐受的研究[J].现代免疫学,2006,26(2):139-142. 被引量:3
  • 3Josefson A. A new method of treatment-intraossal injections. Acta Med Scand, 1934, 81: 550-564.
  • 4Kushida T, Inaba M, Hisha H, et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/Ipr mice. Blood, 2001,97:3292-3299.
  • 5Yahata T, Ando K, Sato T, et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood,2003, 101: 2905-2913.
  • 6McNiece IK, Almeida-Porada G, Shpall E J, et al. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp Hematol, 2002, 30:612-616.
  • 7Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med, 2001, 344:1870-1871.
  • 8Jetmore A, Plett PA, Tong X, et al. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34 ( + )cells transplanted into conditioned NOD/SCID recipients. Blood,2002,99:1585-1593.
  • 9Kushida T, Inaba M, Hisha H, et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/1pr mice.Blood, 2001, 97: 3292-3299.
  • 10Thomas W, Mohamed H Sayegh. Anti-CD154 or CTLA4-Ig obviate the need for thyrnic irradiation in a nonmyeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation, 1999, 68:1348-1345.

共引文献16

同被引文献54

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部